(Q53063435)

English

Evaluation of humoral and cellular immune response of BALB/c mice immunized with a recombinant fragment of MSP1a from Anaplasma marginale using carbon nanotubes as a carrier molecule.

scientific article published on 4 March 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24606864

Evaluation of humoral and cellular immune response of BALB/c mice immunized with a recombinant fragment of MSP1a from Anaplasma marginale using carbon nanotubes as a carrier molecule. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24606864

0 references

Anaplasma marginale

object named as

Anaplasma marginale

1 reference

based on heuristic

inferred from title

Ricardo T. Fujiwara

7

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24606864

Alice F Versiani

object named as

Alice F Versiani

3

0 references

author name string

Bruna T Silvestre

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24606864

Élida M L Rabelo

2

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24606864

Flávio G da Fonseca

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24606864

Júlia A G Silveira

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24606864

Lilian L Bueno

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24606864

Múcio F B Ribeiro

8

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24606864

language of work or name

0 references

publication date

4 March 2014

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24606864

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24606864

32

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24606864

19

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24606864

2160-2166

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24606864

Anaplasma infections in wild and domestic ruminants: a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

The natural history of Anaplasma marginale

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

Evaluating the effectiveness of an inactivated vaccine from Anaplasma marginale derived from tick cell culture

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

Immunization with an isolate-common surface protein protects cattle against anaplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

Recombinant vaccinia virus expression of Anaplasma marginale surface protein MSP-1a: effect of promoters, leader sequences and GPI anchor sequence on antibody response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

CD4(+) T lymphocytes from calves immunized with Anaplasma marginale major surface protein 1 (MSP1), a heteromeric complex of MSP1a and MSP1b, preferentially recognize the MSP1a carboxyl terminus that is conserved among strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

Characterization of the functional domain of major surface protein 1a involved in adhesion of the rickettsia Anaplasma marginale to host cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

Antigens and alternatives for control of Anaplasma marginale infection in cattle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

Characterization of a neutralization-sensitive epitope on the Am 105 surface protein of Anaplasma marginale

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

Differential adhesion of major surface proteins 1a and 1b of the ehrlichial cattle pathogen Anaplasma marginale to bovine erythrocytes and tick cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

Mapping of B-cell epitopes in the N-terminal repeated peptides of Anaplasma marginale major surface protein 1a and characterization of the humoral immune response of cattle immunized with recombinant and whole organism antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

Carbon nanotubes as functional excipients for nanomedicines: II. Drug delivery and biocompatibility issues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

Biomedical applications of functionalised carbon nanotubes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

Protection in the absence of exclusion between two Brazilian isolates of Anaplasma marginale in experimentally infected calves

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

Immunization of cattle with Anaplasma marginale derived from tick cell culture

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

Vaccination of cattle with Anaplasma marginale derived from tick cell culture and bovine erythrocytes followed by challenge-exposure with infected ticks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

Linkage between Anaplasma marginale outer membrane proteins enhances immunogenicity but is not required for protection from challenge.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

Translocation of bioactive peptides across cell membranes by carbon nanotubes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

Nanotube molecular transporters: internalization of carbon nanotube-protein conjugates into Mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

Molecular basis for vaccine development against the ehrlichial pathogen Anaplasma marginale

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

Immune response of BALB/c mouse immunized with recombinant MSPs proteins of Anaplasma marginale binding to immunostimulant complex (ISCOM).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

Induced immune response of DNA vaccine encoding an association MSP1a, MSP1b, and MSP5 antigens of Anaplasma marginale

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

Epitope-based vaccines with the Anaplasma marginale MSP1a functional motif induce a balanced humoral and cellular immune response in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

Gamma interferon dominates the murine cytokine response to the agent of human granulocytic ehrlichiosis and helps to control the degree of early rickettsemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

Anaplasma phagocytophilum infects mast cells via alpha1,3-fucosylated but not sialylated glycans and inhibits IgE-mediated cytokine production and histamine release

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

IL-17A produced by gammadelta T cells plays a critical role in innate immunity against listeria monocytogenes infection in the liver

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

Induction of protective immunity by using Anaplasma marginale initial body membranes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

based on heuristic

inferred from DOI database lookup

CD4(+) T-lymphocyte and immunoglobulin G2 responses in calves immunized with Anaplasma marginale outer membranes and protected against homologous challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

based on heuristic

inferred from DOI database lookup

Putative adhesins of Anaplasma marginale: major surface polypeptides 1a and 1b.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

based on heuristic

inferred from DOI database lookup

The repertoire of Anaplasma marginale antigens recognized by CD4(+) T-lymphocyte clones from protectively immunized cattle is diverse and includes major surface protein 2 (MSP-2) and MSP-3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

based on heuristic

inferred from DOI database lookup

Depletion of gamma interferon and tumor necrosis factor alpha in mice with Rickettsia conorii-infected endothelium: impairment of rickettsicidal nitric oxide production resulting in fatal, overwhelming rickettsial disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.062

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2014.02.062

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24606864

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24606864

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53063435&oldid=1677385295"